Proteomic and lipidomic analysis of the mechanism underlying astragaloside IV in mitigating ferroptosis through hypoxia-inducible factor 1alpha/heme oxygenase 1 pathway in renal tubular epithelial cells in diabetic kidney disease
lifestyle interventions and prescribed medications remain the evidence-based approach for type 2 diabetes
Recalls & Warnings July 01, 2003 Direct Marketers of Weight Loss, Impotence, and Arthritis Supplements Charged with Deceptive Claims On July 1, 2003, the Federal Trade Commission (FTC) announced three enforcement actions against direct marketers of weight-loss products containing ephedra
PD is characterized by both motor impairments, such as tremors and rigidity, and non-motor symptoms, including gastrointestinal dysfunction, mood disorders, and cognitive decline 4
Medications for obesity: a review
Eating behavior has been hypothesized to influence therapeutic efficacy, but supporting evidence remains limited